Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

39
Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy [email protected] JOINT SYMPOSIUM WITH JACCT - Bologna, 25/9/2008 - 16:30-17:45 (12’) CHRONIC TOTAL OCCLUSIONS: CHRONIC TOTAL OCCLUSIONS: WHY BOTHER? WHY BOTHER?

description

CHRONIC TOTAL OCCLUSIONS: WHY BOTHER?. Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy [email protected]. JOINT SYMPOSIUM WITH JACCT - Bologna, 25/9/2008 - 16:30-17:45 (12’). LEARNING OBJECTIVES. Defining the chronic total occlusion (CTO) context - PowerPoint PPT Presentation

Transcript of Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Page 1: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Giuseppe Biondi ZoccaiUniversity of Turin, Turin, Italy

METCARDIO, Turin, [email protected]

JOINT SYMPOSIUM WITH JACCT - Bologna, 25/9/2008 - 16:30-17:45 (12’)

CHRONIC TOTAL OCCLUSIONS: CHRONIC TOTAL OCCLUSIONS:

WHY BOTHER?WHY BOTHER?

Page 2: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

LEARNING OBJECTIVES

Defining the chronic total

occlusion (CTO) context

Pathophysiologic basis of CTO

Clinical evidence on CTO

Page 3: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

LEARNING OBJECTIVES

Defining the chronic total

occlusion (CTO) context

Pathophysiologic basis of CTO

Clinical evidence on CTO

Page 4: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

MVD

Incomplete revascularization

SymptomsLV function

Freedom from major adverse events, heart failure and anginaFreedom from major adverse events, heart failure and angina

Open artery hypothesis

Silent ischemia

Periprocedural necrosis

DES thrombosis

Avoiding CABG

SCOPE OF THE PROBLEM

Page 5: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

INCIDENCE AND IMPACT

Page 6: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

CLUSTERING WITH MULTIVESSEL DISEASE

Page 7: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

LEARNING OBJECTIVES

Defining the chronic total

occlusion (CTO) context

Pathophysiologic basis of CTO

Clinical evidence on CTO

Page 8: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Abbate et al, Cardiology 2003;100:196-206

NATURAL HISTORY OF UNFAVORABLE CARDIAC REMODELING

Page 9: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

POTENTIAL IMPACT OF PCI ON CARDIAC REMODELING

Abbate et al, Cardiology 2003;100:196-206

Page 10: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Abbate et al, J Cell Physiol 2002;193:145-153

THE OPEN ARTERY HYPOTHESIS: TRUE OR FALSE?

Page 11: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

CORONARY OCCLUSION AND MYOCARDIAL APOPTOSIS

Page 12: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Abbate et al, Circulation 2002;106;1051-1054

PERMANENT CORONARY OCCLUSION AND INCREASES

MYOCARDIAL APOPTOSIS

Page 13: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Biondi-Zoccai et al, Int J Cardiol 2004;94:105-110

DETRIMENTAL IMPACT OF CTO IN MULTIVESSEL DISEASE

Page 14: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Moretti et al, J Cardiovasc Med 2008 – in press

0

0,1

0,2

0,3

0,4

0,5

0,6

0,7

0,8

0,9

1

0,00 0,09 0,13 0,16 0,17 0,21 0,25 0,28 0,31 0,34 0,36 0,38 0,40 0,42 0,43 0,47 0,69 1,00

sens

spec

FFRcoll

COLLATERALS MOST OFTEN FAIL TO PREVENT SYMPTOMATIC ISCHEMIA

Page 15: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Before PCI for CTO

5 months after PCI for CTO

PCI MAY PROVIDE CARDIAC REMODELING BENEFITS

Baks et al, J Am Coll Cardiol 2006;47:721-725

Page 16: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Pristipino et al, Am J Cardiol 2005;96:769-72

PCI MAY PROVIDE ELECTRICAL STABILIZATION

Page 17: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Pristipino et al, Am J Cardiol 2005;96:769-72

SUCCESSFUL PCI FOR CTO

UNSUCCESSFUL PCI FOR CTO

PCI MAY PROVIDE ELECTRICAL STABILIZATION

Page 18: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

LEARNING OBJECTIVES

Defining the chronic total

occlusion (CTO) context

Pathophysiologic basis of CTO

Clinical evidence on CTO

Page 19: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

50

60

70

80

90

100

TOAST-GISE (1 y) Thoraxcenter (2 y) MAHA (10 y)

Success

Failure

P=0.001

Long

-ter

m s

urvi

val

follo

win

g C

TO

att

empt

(%

) P=0.002P=0.01

SELECTION BIAS MAY UNDERMINE PROMISING LONG-TERM DATA FROM

NON-RANDOMIZED STUDIES

Page 20: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Suero et al, J Am Coll Cardiol 2001;38:409-14; Safley et al, J Am Coll Cardiol Intv 2008;1:295-302

SELECTION BIAS MAY UNDERMINE PROMISING LONG-TERM DATA FROM

NON-RANDOMIZED STUDIES

and benefit mainly due to LAD recanalization

Page 21: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

INTERVENTIONISTS’ NEW OATH:I WILL NOT TREAT CTO

OAT

TRIAL

Hochman, New Engl J Med 2006;355:2395-2407

Page 22: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

INTERVENTIONISTS’ NEW OATH:I WILL NOT TREAT CTO

Hochman, New Engl J Med 2006;355:2395-2407

Page 23: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

ONLINE ONLY ONLINE ONLY SUPPLEMENT – Hochman et al, New Engl J Med 2006;355:2395-2407

BUT OATHS ARE DIFFICULT TO MAINTAIN…

OAT

TRIAL

Page 24: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

PCI WITH STENTS FOR CTO SURELY CARRIES A PERI-PROCEDURAL RISK

Page 25: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Agostoni et al, Am Heart J 2006;151:682-689

MI rate

MACE rate

PCI WITH STENTS FOR CTO SURELY CARRIES A PERI-PROCEDURAL RISK

Page 26: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

SHOULD THUS INTERVENTIONISTS BE DISCOURAGED?

Boden et al, New Engl J Med 2007;356:1503-1516

Page 27: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Boden et al, New Engl J Med 2007;356:1503-1516

SHOULD THUS INTERVENTIONISTS BE DISCOURAGED?

Page 28: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Erne et al, JAMA 2007;297:1985-1991

NOT SWISS INTERVENTIONISTS!

SWISSI-2

TRIAL

Page 29: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

AND NOT PROVIDED ISCHEMIC MYOCARDIUM IS VISUALIZED…

Shaw et al, Circulation 2008;117:1283-1291

COURAGE SUB-STUDY

Page 30: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Shaw et al, Circulation 2008;117:1283-1291

AND NOT PROVIDED ISCHEMIC MYOCARDIUM IS VISUALIZED…

Page 31: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Abbate et al, J Am Coll Cardiol 2008;51:956-64

IS ANY SYNTHESIS POSSIBLE?

Page 32: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Abbate et al, J Am Coll Cardiol 2008;51:956-64

IS ANY SYNTHESIS POSSIBLE?

Page 33: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

Appleton et al, Catheter Cardiovasc Interv 2008;71:772-81

IS ANY SYNTHESIS POSSIBLE?

Page 34: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

IS ANY SYNTHESIS POSSIBLE?

Appleton et al, Catheter Cardiovasc Interv 2008;71:772-81

Page 35: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

TAKE HOME MESSAGES

Page 36: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

1. NOT ALL CTOS ARE BORN EQUAL

Page 37: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

2. BOTH PCI AND MAXIMAL MEDICAL RX ARE PIVOTAL

Page 38: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

All from

All different

3. AVOID ROUTINE (AGGRESSIVE) PCI FOR ALL CTO, AS EVERY SINGLE ONE

SHOULD BE HANDLED DIFFERENTLY

Page 39: Giuseppe Biondi Zoccai University of Turin, Turin, Italy METCARDIO, Turin, Italy

For further slides on these topics please feel free to visit the

metcardio.org website:

http://www.metcardio.org/slides.html